Farrah C.

Farrah C. has extensive work experience in the biopharmaceutical industry. Farrah started their career at Lonza in 2005, where they worked in Manufacturing Science and Technology. Farrah then moved on to Shire Pharmaceuticals in 2007, where they worked in Technical Operations. In 2010, they joined ImmunoGen, Inc. as part of the External Manufacturing team. Farrah then worked at Novartis from 2017 to 2019, focusing on Alliance Management in NIBR BD&L. From 2019 to 2021, they worked at Epizyme in Pharmaceutical Sciences. In 2021, Farrah joined Xilio Therapeutics, Inc. in CMC Operations. Currently, they are the Senior Director of CMC Strategic Planning & Operations at Generate Biomedicines since December 2022.

Farrah C. has a Master of Business Administration (MBA) degree in Supply Chain and International Management from the D'Amore-McKim School of Business at Northeastern University. Farrah also holds a Bachelor of Science (BS) degree in Biology from Northeastern University.